Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, is the David H. Johnson Endowed Chair of Surgical and Medical Oncology, VICC Associate Director, Strategic Relations and Research Partnerships, and the Executive Director of the Young Adults Cancers Program at Vanderbilt-Ingram Cancer Center. She currently sits on the Board of Directors for the national patient advocacy group, Fight Colorectal Cancer. She is a highly sought mentor and serves on the T-32 grant and serves as a Professional Development Mentor. She is a co-investigator for the recent GI SPORE submission. She is also a Fellow of the Executive Leadership in Academic Medicine (ELAM), Class of 2022. She continues to assume leadership positions devoted to development of phase I-III clinical trials using novel therapeutics for biomarker discovery and enhanced drug utilization in colorectal, appendiceal and anal cancer. She was awarded the VUMC Biomedical Scientific Impact Award in 2023.
She is also a board member of Fight CRC.
